745 related articles for article (PubMed ID: 37312116)
1. Nanomaterials in tumor immunotherapy: new strategies and challenges.
Zhu X; Li S
Mol Cancer; 2023 Jun; 22(1):94. PubMed ID: 37312116
[TBL] [Abstract][Full Text] [Related]
2. Nanomaterials: Breaking through the bottleneck of tumor immunotherapy.
Kang Y; Li S
Int J Biol Macromol; 2023 Mar; 230():123159. PubMed ID: 36610572
[TBL] [Abstract][Full Text] [Related]
3. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy.
Chen Z; Yue Z; Yang K; Shen C; Cheng Z; Zhou X; Li S
Adv Healthc Mater; 2023 Oct; 12(26):e2300882. PubMed ID: 37539730
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Nanomaterials for Cancer Immunotherapy.
Li J; Lu W; Yang Y; Xiang R; Ling Y; Yu C; Zhou Y
Adv Sci (Weinh); 2023 Feb; 10(6):e2204932. PubMed ID: 36567305
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional inorganic nanomaterials for cancer photoimmunotherapy.
Tang L; Zhang A; Zhang Z; Zhao Q; Li J; Mei Y; Yin Y; Wang W
Cancer Commun (Lond); 2022 Feb; 42(2):141-163. PubMed ID: 35001556
[TBL] [Abstract][Full Text] [Related]
6. DNA-based Nanomaterials in the Immunotherapy.
Huang H; Gao S; Cai X
Curr Drug Metab; 2023; 24(5):367-384. PubMed ID: 37069706
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy.
Li SR; Huo FY; Wang HQ; Wang J; Xu C; Liu B; Bu LL
J Nanobiotechnology; 2022 Jun; 20(1):277. PubMed ID: 35701847
[TBL] [Abstract][Full Text] [Related]
8. Bioactive inorganic nanomaterials for cancer theranostics.
Pei Z; Lei H; Cheng L
Chem Soc Rev; 2023 Mar; 52(6):2031-2081. PubMed ID: 36633202
[TBL] [Abstract][Full Text] [Related]
9. Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy.
Guo L; Yang J; Wang H; Yi Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067480
[TBL] [Abstract][Full Text] [Related]
10. Nanomaterials: A powerful tool for tumor immunotherapy.
Chen Z; Yue Z; Wang R; Yang K; Li S
Front Immunol; 2022; 13():979469. PubMed ID: 36072591
[TBL] [Abstract][Full Text] [Related]
11. The Refined Application and Evolution of Nanotechnology in Enhancing Radiosensitivity During Radiotherapy: Transitioning from Gold Nanoparticles to Multifunctional Nanomaterials.
Zhang A; Gao L
Int J Nanomedicine; 2023; 18():6233-6256. PubMed ID: 37936951
[TBL] [Abstract][Full Text] [Related]
12. Research progress of the engagement of inorganic nanomaterials in cancer immunotherapy.
Peng T; Xu T; Liu X
Drug Deliv; 2022 Dec; 29(1):1914-1932. PubMed ID: 35748543
[TBL] [Abstract][Full Text] [Related]
13. Nanomaterials Mediated Multimodal Combined Treatment for Cancer.
Wang C; Zhang Q; Chen M; Hu A; Wei B; Yang Z
Mini Rev Med Chem; 2023; 23(16):1623-1641. PubMed ID: 36650648
[TBL] [Abstract][Full Text] [Related]
14. Activation of cancer immunotherapy by nanomedicine.
Wang L; Xu H; Weng L; Sun J; Jin Y; Xiao C
Front Pharmacol; 2022; 13():1041073. PubMed ID: 36618938
[TBL] [Abstract][Full Text] [Related]
15. Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.
Lenders V; Koutsoumpou X; Sargsian A; Manshian BB
Nanoscale Adv; 2020 Nov; 2(11):5046-5089. PubMed ID: 36132021
[TBL] [Abstract][Full Text] [Related]
16. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy by immune checkpoint blockade and its advanced application using bio-nanomaterials.
Yadav D; Kwak M; Chauhan PS; Puranik N; Lee PCW; Jin JO
Semin Cancer Biol; 2022 Nov; 86(Pt 2):909-922. PubMed ID: 35181474
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
19. Cancer Immunotherapy Elicited by Immunogenic Cell Death Based on Smart Nanomaterials.
Yang M; Zhang C; Wang R; Wu X; Li H; Yoon J
Small Methods; 2023 May; 7(5):e2201381. PubMed ID: 36609838
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterial-Based Drug Delivery Systems: A New Weapon for Cancer Immunotherapy.
Jiang Z; Zhang W; Zhang J; Liu T; Xing J; Zhang H; Tang D
Int J Nanomedicine; 2022; 17():4677-4696. PubMed ID: 36211025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
